Back to Near-Term Bullish on SPX and Nasdaq 100; Supports Held at SPX 6480-6520 and QQQ $580-583
Back to Near-Term Bullish on $SPX and Nasdaq 100 $NDX; Crucial Supports Held at 6480-6520 on SPX and $580-$583 on $QQQ, we are near-term bullish as...
216 Views
Downgrading Financials to Underweight; Growth Themes Galore; Health Care Breaking Out
Downgrading Financials $XLF to Underweight; Growth Themes Galore: quantum, nuclear, hydrogen, space, robotics, drones, data centers, solar,...
519 Views
U.S. Equity Strategy: Round Trip Back To Resistance
Our base case continues to be for near-term consolidation while the market determines the implications of states’ reopening (i.e., the...
354 Views
U.S. Equities: Test Of The Lows Coming?
Now that the initial/primary low has been established and with the S&P 500 roughly 20% off the lows, we believe it is time to map out potential...
481 Views
Adaptive Biotechnologies IPO: Immune to Grow and Succeed; and the Future Looks Good
Adaptive Biotechnologies (ADPT US)Â has filed for an IPO in the US to raise approximately US$181m and has set an IPO price range of US$15-17 per...
429 Views
No more insights